Effectiveness of Enhanced Recovery After Surgery (ERAS) in Gynecologic Oncology Surgery

Saleh, Mawada; El Shahat, Mohamed Nezar; Fyala, Emad; Ismael, Khaled Samir

doi:10.21608/ebwhj.2025.384549.1459

Effectiveness of Enhanced Recovery After Surgery (ERAS) in Gynecologic Oncology Surgery

Document Type : Original Article

Authors

¹ department of obstetrics and gynecology , mansoura university

² department of obstetrics and gynecology

³ deparment of obsterrics and gynecology

⁴ department of obstetrics and gynecology mansoura university

10.21608/ebwhj.2025.384549.1459

Abstract

Objective: The current study aimed to evaluate the effectiveness of implementation of enhanced recovery after surgery in patients with gynecologic cancer undergoing open surgery at our institute.
Methods: This was a randomized controlled trial done during the period of August 2022 to August 2023. The study included 100 participants with gynecologic cancer who were treated with open surgery at our institute. Patients were randomly assigned to conventional group (50 patients) who received the usual management, and the ERAS group (50 patients) who were managed by preoperative, intraoperative, and postoperative ERAS protocol. The outcome measures were length of hospital stay and perioperative complications.
Results: The mean time required for return of bowel function was significantly longer in group A (conventional) than in group B (ERAS) (30.72±7.72 hours versus 18.96±7.21 respectively; P value 0.001). The length of hospital stay was significantly longer in group A than group B (5.66±2.08 days versus 3.92±1.45 days respectively; P value 0.001). 17 cases (34%) of group A had postoperative nausea and vomiting (needing antiemetics) despite only 6 cases (12%) of group B (P value 0.01). Also 28 cases (56%) of group A had post operative moderate to severe pain despite only 14 cases (28%) of group B (P value 0.005). There was no significant difference in postoperative ileus, blood transfusion or readmission within 30 days between both groups.
Conclusions: We can conclude that implementation of ERAS protocol on patients with gynecologic cancers undergoing surgery had confirmed previous results of shorter length of hospital stay, early return of bowel function, less postoperative pain scores with no increase in perioperative complications. Implementation of ERAS guidelines should be encouraged in low resource countries.

Keywords